Lars Lund-Roland is a management consultant and associate partner at Narum Gruppen and has for the last three and a half years been CEO of Bringwell AB (publ), a Nordic health and welfare company listed in Stockholm, that commercializes OTC pharmaceuticals, nutrition and food supplements. Prior to this, he has been Managing Director of MSD Norway (Merck & Co Inc. subsidiary) for 10 years and has gained more than twenty-five years of big-pharma experience from various executive positions within marketing and sales at Merck & Co., Inc. Mr Lund-Roland currently holds board positions at Vaccibody AS and Idia AS and has served as Board member of Infodoc AS and Health Tech AS, two Norwegian health technology companies, as well as on the board of the Norwegian Association of Pharmaceutical Manufacturers. He is a Business Economist Graduate from Norwegian Business School BI, has a BSc in Healthcare from Buskerud University College and leadership education from the Sr. Executive programs at Columbia Business School and Harvard. Mr Lund-Roland is a Norwegian citizen, and resides in Norway.